The $15 Special...
Here is your bimonthly commentary from Executive Editor David Fish and a capsule review of our featured stock. As a subscriber, you are entitled to the reduced service fee $15 (instead of $25 or $50), if you choose to enroll in the DRIP of this company before Friday, 02/20/2009, at 12:00 noon (EST). All orders must be received by the deadline in order for the reduced fee to be valid.

NOTE: To obtain the $15 fee, you must use the link on this email. You may also accept the option to print out the ONLINE Order Form and mail that in, provided you do so within the deadline. Regular Order Forms with the above symbol written on it will NOT be granted the $15 service fee.

Our current Special is...* Beckman Coulter Inc. (BEC)

Founded in 1934, Beckman Instruments was spun off by SmithKline after the latter merged with Beecham in 1989 and acquired Coulter in 1997. The company designs and manufactures laboratory instruments, including centrifuges, chromatographs, spectrophotometers, nuclear counters, and systems that detect and quantify various substances in blood, urine, and other fluids. Clinical diagnostics account for about 83% of its sales, whereas biomedical research accounts for the other 17%. Roughly half of its $3.1 billion in annual sales originate overseas and the company spends nearly 10% of its revenues on research and development. Consensus estimates called for the company to have earned about $3.57 per share in 2008, compared with $3.25 a year earlier, and to go on to earn about $3.91 per share in 2009. The dividend should be increased in the first quarter for the 18th consecutive year.

Click here to go to an order form for this company. The enrollment fee is only $15 until Friday, 02/20/2009, at 12:00 noon (EST).

https://www.directinvesting.com/securefiles/static/find_company_s.cfm?s=BEC&s10=y

Commentary
Reverse Psychology
Warren Buffett is credited with having said that successful investors should be fearful when others are greedy and greedy when others are fearful. That really is just another way of saying that we should buy low and sell high, but it adds an important element, which is the role of psychology in the stock market. The current mood is undeniably fearful, and that fear has reached an extreme level in recent months. Many stocks have lost more than half their value since the October 2007 peak, some with good reason. But reason is not always involved in such declines and we can easily lose sight of the fact that not all companies are as bad as the market would indicate. Some have sold off simply because we are in a recessionary environment that may reduce their profits temporarily. The current recession, like most, is the result of a period of excess, which necessarily means contraction, as that excess is eliminated. In this case, we have come through a period of excess liquidity and inflated housing values, as well as overly volatile oil and commodity prices. Consolidation is transforming the financial and automotive industries, and the job losses we are witnessing are a reminder of just how interrelated global commerce has become. In other words, it is a learning experience and the first thing we need to learn is that recession is simply part of the perpetual business cycle. It will end, just as all recessions do. The effect on the stock market will also end at some point, and prices will move higher. The only question is whether or not we will have seized the opportunity to buy low from those who are gripped by fear, and whether we will know enough to sell high to those who are driven by greed in the future.
Sincerely,
Moneypaper Inc.
555 Theodore Fremd Ave Suite B-103
Rye, NY 10580
Tel: 1(800) 388 9993 or (914) 925 0022
Fax: (914) 921 9318
Email: news@moneypaper.com